FIRM FIXED PRICE

ACTELION PHARMACEUTICALS US, INC. - OPSUMIT 10MG-QTY 2 @ 6,426.78 FEB. ORDER - $12,853.56

PIID: 15B50526F00000092
Signed Date: Feb 19, 2026Effective Date: Feb 1, 2026End Date: Closed on Feb 28, 2026
Award $
$13K
Vendor
ACTELION PHARMACEUTICALS US, INC.
NAICS
325412
Signed Date
Feb 19, 2026

Key Details

Dollars Obligated
$12,853.56
Base & All Options
$12,853.56
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
Q517 - PHARMACY SERVICES
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
LAKE MARY, FL, 327466216, CD-FL-07

Description

OPSUMIT 10MG-QTY 2 @ 6,426.78 FEB. ORDER - $12,853.56

Context & Analysis

On Feb 19, 2026, Department of Justice obligated $12,853.56 to ACTELION PHARMACEUTICALS US, INC. for opsumit 10mg-qty 2 @ 6,426.78 feb. order - $12,853.56. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in LAKE MARY, FL.

Contractor Information

UEI: H5BMHLMMNA28
CAGE Code: 33TN9
Location: TITUSVILLE, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related